Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines

Cancer Genetics and Cytogenetics

Volumn 184, Issue 1, 2008, Pages 38-43

  Giefing, Maciej ^a,b   Martin Subero, Jose Ignacio ^b   Kiwerska, Katarzyna ^a   Jarmuz, Małgorzata ^a   Grenman, Reidar ^c   Siebert, Reiner ^b   Szyfter, Krzysztof ^a,d  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b UNIVERSITY OF KIEL   (Germany)

^c Department of Medical Biochemistry ^*  (Finland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CDKN2A GENE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LARYNX CARCINOMA; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STK17A GENE; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA PRIMERS; HOMOZYGOTE; HUMANS; LARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 44949164778     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.03.004     Document Type: Article

References (18)

1. Levi F., Lucchini F., Negri E., Zatonski W., Boyle P., and La Vecchia C. Trends in cancer mortality in the European Union and accession countries, 1980-2000. Ann Oncol 15 (2004) 1425-1431
2. Sasiadek M.M., Stembalska-Kozlowska A., Smigiel R., Ramsey D., Kayademir T., and Blin N. Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. Br J Cancer 90 (2004) 1594-1599
3. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., Stockert E., Day III R.S., Johnson B.E., and Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 (1994) 436-440
4. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
5. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., da Costa L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., and Kern S.E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271 (1996) 350-353
6. Versteege I., Sévenet N., Lange J., Rousseau-Merck M.F., Ambros P., Handgretinger R., Aurias A., and Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394 (1998) 203-206
7. Jarmuz M., Golusinski W., Grenman R., and Szyfter K. Analysis of chromosome aberrations in cell lines derived from laryngeal cancer in relation to tumor progression. Eur Arch Otorhinolaryngol 259 (2002) 269-273
8. Jarmuz M., Grenman R., Golusinski W., and Szyfter K. Aberrations of 11q13 in laryngeal squamous cell lines and their prognostic significance. Cancer Genet Cytogenet 160 (2005) 82-88
9. Iafrate A.J., Feuk L., Rivera M.N., Listewnik M.L., Donahoe P.K., Qi Y., Scherer S.W., and Lee C. Detection of large-scale variation in the human genome. Nat Genet 36 (2004) 949-951
10. She X., Jiang Z., Clark R.A., Liu G., Cheng Z., Tuzun E., Church D.M., Sutton G., Halpern A.L., and Eichler E.E. Shotgun sequence assembly and recent segmental duplications within the human genome. Nature 431 (2004) 927-930
11. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., and Haussler D. The Human Genome Browser at UCSC. Genome Res 12 (2002) 996-1006
12. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics methods and protocols. Methods in Molecular Biology 132 (2000), Humana Press, Totowa, NJ 365-386
13. Washietl S., Hofacker I.L., and Stadler P.F. Fast and reliable prediction of noncoding RNAs. Proc Natl Acad Sci U S A 102 (2005) 2454-2459
14. Sharpless N.E., and DePinho R.A. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 9 (1999) 22-30
15. Sanz-Ortega J., Valor C., Saez M.C., Ortega L., Sierra E., Poch J., Hernandez S., and Sanz-Esponera J. 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation. Histol Histopathol 18 (2003) 1053-1057
16. Sasiadek M.M., Stembalska-Kozlowska A., Smigiel R., Ramsey D., Kayademir T., and Blin N. Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. Br J Cancer 90 (2004) 1594-1599
17. INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132 (2006) 409-415
18. Tadokoro H., Shigihara T., Ikeda T., Takase M., and Suyama M. Two distinct pathways of p16 gene inactivation in gallbladder cancer. World J Gastroenterol 13 (2007) 6396-6403